Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PFDN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHCHD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF4EBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC52A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSENEN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
P2RX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NME6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL12RB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C16orf59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YBEY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKLE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FADS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGF9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF170 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on